Summary
Tests of the new diet drug Acomplia show that users lost 10 percent or more of their body weight and kept that weight off for two years. The drug impedes the sensation of hunger by suppressing the part of the brain that responds to pleasure from food. It also helped some users quit smoking. Much of the weight loss on Acomplia was from around the waist, which researchers say is positive, since waist fat has been tied to increased risk of heart disease and stroke.
Original source:
http://my.webmd.com/content/article/101/106464.htm
Details
The experimental diet drug Acomplia helps keep off unwanted pounds for up to two years, new research shows.
After two years of treatment, patients in the study maintained a 16-pound weight loss.
More than a third of patients taking the drug lost 10% of their body weight.
This new research is the fourth positive study of the drug, showing that Acomplia can take off pounds and help people stop smoking.Acomplia can take off pounds and help people stop smoking.
"We can now say that we have robust data that can be replicated that shows [Acomplia] helps people lose weight and maintain that weight loss,shows [Acomplia] helps people lose weight and maintain that weight loss," says Van Gaal, who is a professor of diabetology, metabolism, and clinical nutrition at the University of Antwerp in Belgium.
Participants in the study were randomly selected to take either low-dose Acomplia (5 mg), high-dose Acomplia (20 mg), or a placebo.
Additionally, all patients were told to reduce their daily caloric intake by 600 calories.
After two years, the patients taking 20 mg lost an average of 16 pounds and kept the weight off.
Perhaps even more encouraging, says Van Gaal, is that the patients taking Acomplia dropped inches from their waist, which is especially significant since expanding waistlines are associated with increased risk of heart disease and diabetes.expanding waistlines are associated with increased risk of heart disease and diabetes.
The average waist reduction was 3 inches for patients taking 20 mg and 1.3 inches for those on the lower dose.
After the first year of treatment, 39% of patients taking high-dose
Acomplia were able to reach a goal of losing 10% of their weight.
About the author: Mike Adams is a natural health author and award-winning journalist with a passion for teaching people how to improve their health He has authored and published thousands of articles, interviews, consumers guides, and books on topics like health and the environment, and he has published numerous courses on preparedness and survival, including financial preparedness, emergency food supplies, urban survival and tactical self-defense. Adams is a trusted, independent journalist who receives no money or promotional fees whatsoever to write about other companies' products. In 2010, Adams launched TV.NaturalNews.com, a natural health video site featuring videos on holistic health and green living. He also launched an online retailer of environmentally-friendly products (BetterLifeGoods.com) and uses a portion of its profits to help fund non-profit endeavors. He's also a veteran of the software technology industry, having founded a personalized mass email software product used to deliver email newsletters to subscribers. Adams also serves as the executive director of the Consumer Wellness Center, a non-profit consumer protection group, and enjoys outdoor activities, nature photography, Pilates and martial arts training. He's also author of numerous health books published by Truth Publishing and is the creator of several consumer-oriented grassroots campaigns, including the Spam. Don't Buy It! campaign, and the free downloadable Honest Food Guide. He also created the free reference sites HerbReference.com and HealingFoodReference.com. Adams believes in free speech, free access to nutritional supplements and the ending of corporate control over medicines, genes and seeds. Known as the 'Health Ranger,' Adams' personal health statistics and mission statements are located at www.HealthRanger.org
Have comments on this article? Post them here:
people have commented on this article.
Wednesday, March 16, 2005
Email this article to a friend
Share
this article on: 
